Chapter 23: The Breast: Pathology and Disease

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

The Breast: Pathology and Disease guide to mammary pathology explores the complex physiological and neoplastic transformations of the breast, starting with normal anatomical structures like the terminal duct lobular unit and developmental anomalies such as ectopic milk line remnants and accessory axillary tissue. The material transitions into benign clinical presentations, detailing inflammatory conditions like lactational mastitis and squamous metaplasia of the lactiferous ducts (Zuska disease), while carefully distinguishing these from mimics of malignancy like fat necrosis and duct ectasia. A significant portion of the analysis is dedicated to the spectrum of epithelial proliferations, ranging from nonproliferative fibrocystic changes involving cysts and adenosis to high-risk precursor lesions such as atypical ductal and lobular hyperplasia. Central to the discussion is the modern molecular classification of breast cancer, which categorizes invasive carcinomas into distinct clinical subtypes—including Luminal A, Luminal B, HER2-enriched, and Triple-Negative Breast Cancer (TNBC)—based on biomarker expression of estrogen receptors (ER), progesterone receptors (PR), and the HER2/neu oncogene. The exploration of pathogenesis covers both sporadic driver mutations like PIK3CA and hereditary susceptibility through high-penetrance germline mutations in BRCA1, BRCA2, and TP53. Furthermore, the text provides an in-depth look at morphological variants, such as invasive lobular and mucinous carcinomas, and discusses the critical role of prognostic factors like the Nottingham Histologic Score and AJCC TNM staging in guiding surgical and systemic therapeutic interventions. Finally, the chapter examines biphasic stromal tumors, contrasting the common benign fibroadenoma with the potentially aggressive phyllodes tumor, and addresses male-specific conditions like gynecomastia, ensuring a thorough understanding of both epithelial and mesenchymal mammary diseases.